Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

ACADIA Pharmaceuticals Inc.(ACAD)

 
123Jump Rating: - Value Gap   Underwriters: Banc of America Sec. LLC
      U.S. Bancorp Piper Jaffrey
Status: Priced   Wachovia Sec.
 
Address: 3911 Sorrento Valley Blvd.
 FiledDate: 02/27/2004
  San Diego,
    
  CA 92121-1402
 Filed Price Range ($): $12.00-14.00
       
Telephone: 858-558-2871 Filed Offer Amount ($ Million): $35.00
       
Fax: 858-558-2872 Shares Offered (Millions): 5
       
Websites: www.acadia-pharm.com Shares Outstanding (Millions): 17
       
Management: Leslie Iversen, Chair.
 IPO Date: 05/26/2004
  Uli Hacksell, CEO/Dir.
    
  Mark Brann, Pres./Dir.
 Final Offer Price ($): $7.00
       
Industry: Biotech Final Offer Size (Millions of Shares): 5.00
       
Employees: 112 Final Offer Amount ($ Million): $35.00
       
Competitors: AstraZeneca
 S-1 Forms:
  Eli Lilly
    
  Pfizer
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1995 300 349 -49 0.00 -52 -.03
1996 438 627 -189 0.00 -192 -.13
1997 835.3 4066.1 -3230.8 0.00 -2981.9 -1.74
1998 1419.4 8342.9 -6923.5 0.00 -6402.5 -3.12
1999 2238.2 10083.3 -7845.1 0.00 -7445.3 -3.57
2000 2768 11242.3 -8474.3 0.00 -7753.7 -3.63
* Nine Months ended September 30, 2000
 
 
© 1999-2008 123jump.com. All rights reserved